文献速递胸部肿瘤放疗放疗物理与技术

质子束治疗肺癌患者肺炎正常组织并发症概率模型的光子模型更新

Updating Photon-Based Normal Tissue Complication Probability Models for Pneumonitis in Patients With Lung Cancer Treated With Proton Beam Therapy.
PubMed 文献 · Pract Radiat Oncol · 2020-05-13

本研究在99例接受质子束治疗(PBT)的局部晚期非小细胞肺癌患者中,外部验证并重新校准了多个基于光子的放射性肺炎(RP)正常组织并发症概率模型。结果显示≥2级RP事件21例(21%),闭环检验仅推荐对荷兰更新QUANTEC模型进行截距调整(-1.2),不推荐斜率更新或系数修订。结论表明既有光子模型经轻微修改后适用于PBT数据。

要点

  • 在PBT治疗的局部晚期NSCLC患者中,≥2级RP发生率为21%。
  • 闭环检验仅推荐对荷兰更新QUANTEC模型调整截距(-1.2)。
  • 不推荐斜率更新或模型系数修订,偏差在数据效能内不显著。

核心结论

  • 既有的广泛使用的光子正常组织并发症概率模型经轻微修改后能很好地拟合PBT数据。

研究设计与样本

  • 外部验证队列由99例连续接受放化疗的局部晚期非小细胞肺癌患者组成,均使用质子束治疗。
  • 回顾性在治疗后3个月和6个月评估放射性肺炎。
  • 评估了光子QUANTEC肺炎模型、调整临床风险因素的QUANTEC模型以及较新的荷兰更新QUANTEC模型。
  • 采用闭环检验程序检验模型更新需求,包括截距重估计、截距/斜率重估计或所有系数重估计。

主要发现

  • ≥2级放射性肺炎事件为21例(21%)。
  • 闭环检验未检测到模型与数据间重大偏差。
  • 仅推荐对荷兰更新QUANTEC模型调整截距(截距更新:-1.2)。
  • 不推荐斜率更新和模型系数修订,因偏差在数据效能内不显著。

关键数值与推荐

  • ≥2级放射性肺炎事件21例(21%)。
  • 荷兰更新QUANTEC模型截距更新值为-1.2。

临床怎么用

  • 经验证和更新的正常组织并发症概率模型可帮助个体化选择特定患者的最优治疗技术。

局限性

  • 偏差在数据效能内不显著,限制了检测模型系数修订需求的能力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: No validated models for predicting the risk of radiation pneumonitis (RP) with proton beam therapy (PBT) currently exist. Our goal was to externally validate and recalibrate multiple established photon-based normal tissue complication probability models for RP in a cohort with locally advanced nonsmall cell lung cancer treated with contemporary doses of chemoradiation using PBT. METHODS AND MATERIALS: The external validation cohort consisted of 99 consecutive patients with locally advanced nonsmall cell lung cancer treated with chemoradiation using PBT. RP was retrospectively scored at 3 and 6 months posttreatment. We evaluated the performance of the photon Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC) pneumonitis model, the QUANTEC model adjusted for clinical risk factors, and the newer Netherlands updated QUANTEC model. A closed testing procedure was performed to test the need for model updating, either by recalibration-in-the-large (re-estimation of intercept), recalibration (re-estimation of intercept/slope), or model revision (re-estimation of all coefficients). RESULTS: There were 21 events (21%) of ≥grade 2 RP. The closed testing procedure on the PBT data set did not detect major deviations between the models and the data and recommended adjustment of the intercept only for the photon-based Netherlands updated QUANTEC model (intercept update: -1.2). However, an update of the slope and revision of the model coefficients were not recommended by the closed testing procedure, as the deviations were not significant within the power of the data. CONCLUSIONS: The similarity between the dose-response relationship for PBT and photons for normal tissue complications has been an assumption until now. We demonstrate that the preexisting, widely used photon based models fit our PBT data well with minor modifications. These now-validated and updated normal tissue complication probability models can aid in individualizing selection of the most optimal treatment technique for a particular patient.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Jain V, Niezink AGH, Frick M, et al. Updating Photon-Based Normal Tissue Complication Probability Models for Pneumonitis in Patients With Lung Cancer Treated With Proton Beam Therapy. Pract Radiat Oncol. 2020. PMID: 32416270. doi:10.1016/j.prro.2020.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。